Arcellx (ACLX) EBITDA Margin (2023 - 2025)
Arcellx's quarterly EBITDA Margin came in at 3505.14% in Q4 2025, down 318985.0% year-on-year from N/an in Q4 2024, and down 209.59% quarter-over-quarter from 1132.2% in Q3 2025.
Arcellx has reported EBITDA Margin for 3 years, with the latest figure at 3505.14% in Q4 2025.
- For the quarter ending Q4 2025, EBITDA Margin fell 318985.0% year-over-year to 3505.14%; the trailing twelve-month figure through Dec 2025 stood at 1027.42% (down 92824.0% YoY), and the FY2025 full-year result was 1027.28%, down 92810.0% from the prior year.
- EBITDA Margin for Q4 2025 stood at 3505.14%, down from 1132.2% in the prior quarter.
- The five-year high for EBITDA Margin was 32.39% in Q4 2023, with the low at 3505.14% in Q4 2025.
- Average EBITDA Margin over 3 years is 598.21%, with a median of 215.41% recorded in 2023.
- Year-over-year, EBITDA Margin jumped 17435 bps in 2024 and sank 318985 bps in 2025.
- Tracing ACLX's EBITDA Margin over 3 years: stood at 32.39% in 2023, then sank by 1073 bps to 315.29% in 2024, then plunged by 1012 bps to 3505.14% in 2025.
- The last three EBITDA Margin figures came in at 3505.14% (Q4 2025), 1132.2% (Q3 2025), and 697.59% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.35% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.24% |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | -3,505.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3,505.14% |
| Sep 30, 2025 | -1,132.20% |
| Jun 30, 2025 | -697.59% |
| Mar 31, 2025 | -768.47% |
| Dec 31, 2024 | -315.29% |
| Sep 30, 2024 | -89.04% |
| Jun 30, 2024 | -100.36% |
| Mar 31, 2024 | -21.03% |
| Dec 31, 2023 | 32.39% |
| Sep 30, 2023 | -263.38% |
| Jun 30, 2023 | -167.44% |
| Mar 31, 2023 | -150.94% |